ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698459; 2) Community: the network communities that were significantly associated with the response to NSC 698459; 3) Molecule: the relationships between components within communities and NSC 698459; 4) MDR: the compounds that were significantly associated with the NSC 698459.

NSC Compound Enrichment Correlation
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.0422011701988039 0.35284157
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0422011701988039 0.42149927
NSC 268965 Benzaldehyde, 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]- 0.0422011701988039 0.27569313
NSC 46598 Null 0.0422011701988039 0.24638677
NSC 606985 Camptothecin Derivative 0.0422011701988039 0.24941969
NSC 618939 Camptothecin Derivative 0.0422011701988039 0.30265504
NSC 623520 Null 0.0422011701988039 0.22842097
NSC 625737 Null 0.0422011701988039 0.37630442
NSC 627759 2'-Phenyl-17a-aza-D-homo-5-androsteno[17,16-c]pyrazol-3.beta.-yl acetate 0.0422011701988039 0.063810817
NSC 660636 2-[1-(4-(4'-acetophenone)piperazino)]-naphthazarin 0.0422011701988039 0.30673796
Total:44  Current:30    [First] [Prev] [Next] [Last]